Natixis’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Natixis’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,000	Closed	-$774	–	1186
2024 Q1	$774	Hold	5,000	–	–	﹤0.01%	962
2023 Q4	$718	Hold	5,000	–	–	﹤0.01%	994
2023 Q3	$893	Buy	+5,000	New	+$6.21K	﹤0.01%	933

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Natixis's GRTX Position: Q2 2024 in Review

Natixis sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 5,000 shares — an estimated $774 sold.

Natixis first reported a position in GRTX in Q3 2023 and held it in 3 quarters. The position peaked at $893 in Q3 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Natixis reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Natixis sold 5,000 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $774.
Natixis first reported a position in Galera Therapeutics, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Natixis's Galera Therapeutics, Inc. Common Stock position peaked at $893 in Q3 2023.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Natixis's 13F filing for Q2 2024, filed 13 Aug 2024.